0000899243-23-011217.txt : 20230412 0000899243-23-011217.hdr.sgml : 20230412 20230412195045 ACCESSION NUMBER: 0000899243-23-011217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230410 FILED AS OF DATE: 20230412 DATE AS OF CHANGE: 20230412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMPSON TODD E CENTRAL INDEX KEY: 0001216477 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 23816811 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-10 0 0001060736 Seagen Inc. SGEN 0001216477 SIMPSON TODD E 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Financial Officer 1 Common Stock 2023-04-10 4 M 0 14980 46.37 A 133926 D Common Stock 2023-04-10 4 S 0 14980 204.14 D 118946 D Common Stock 2023-04-10 4 M 0 40364 46.37 A 159310 D Common Stock 2023-04-10 4 S 0 40364 204.74 D 118946 D Non-Qualified Stock Option (right to buy) 46.37 2023-04-10 4 M 0 14980 0.00 D 2027-08-17 Common Stock 14980 40364 D Non-Qualified Stock Option (right to buy) 46.37 2023-04-10 4 M 0 40364 0.00 D 2027-08-17 Common Stock 40364 0 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. The sales reported in this Form 4 were effected pursuant to a written plan adopted on December 9, 2022 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Reflects sales of common stock executed in multiple transactions at prices ranging from $203.49 to $204.48. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $204.49 to $205.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Options vested 25% on 8/17/18 and monthly thereafter until all the options were fully vested on 8/17/21. By: /s/ Jennifer Prosba For: Todd E. Simpson 2023-04-12